We describe the first case of NMNAT3 deficiency, a novel red cell enzymopathy leading to reduced NAD levels, causing mild hemolytic anemia which improved upon supplementation with NAD-precursors. We therefore propose testing for NMNAT3 variants in unexplained hereditary hemolytic anemia.

Subjects:
Red Cells, Iron, and Erythropoiesis
This content is only available as a PDF.
Copyright © 2025 American Society of Hematology
2025
Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Article PDF first page preview

First page of NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis

Supplemental data

Supplementals- pdf file
Sign in via your Institution